Fund performance: OrbiMed, Canaan, DCM lead early-decade San Francisco portfolioByMark Boslet20 September 2016•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FeaturedInvestorsFeaturedInvestor PerformancePerformance